Skip to content

Opaleye Management Inc., 10% owner at Eton Pharmaceuticals, sold ETON on Jul 7, 2026

Data as of Oct 16

▼ SELL$767K20,000 shares at $38.37Opaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.
Watch ETON
Traded
Jul 7, 2026
Disclosed
Jul 7, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Opaleye Management Inc., 10% owner at Eton Pharmaceuticals, sold ETON on Jul 7, 2026TRADEDDISCLOSED
ETONSimilar stocks (XLV — its sector index fund), rebased to ETON's price on the disclosure day
ETON since disclosure
+33.3%
after the sale
Similar stocks (XLV) since disclosure
+7.5%
XLV — its sector index fund

Change in closing price from Jul 7, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$257Kdisclosed Jul 7 · filed the same day
  2. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$380Kdisclosed Jul 7 · filed 1 day after the trade
  3. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$2.4Mdisclosed Jul 7 · filed 5 days after the trade · late
  4. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$935Kdisclosed Jul 7 · filed 5 days after the trade · late

See every trade on ETON →